WILMINGTON, MA, Jun 02 (MARKET WIRE) —
Implant Sciences Corporation (PINKSHEETS: IMSC), a high technology
supplier of systems and sensors for homeland security and defense
markets, today announced that its products, including the QS-H150
explosives trace detection device, have been selected as ‘Best of Breed
Security Technology’ by Secure Strategy Group (SSG). The company’s
products will be showcased for permanent display and demonstration at the
new SSG Solutions Center in Washington D.C.

Secure Strategy Group is a strategic advisory firm that backs and builds
best of breed growth companies in the security technology field. The firm
identifies technologies that address key growth areas in the homeland
security market. These products and technologies are displayed at Secure
Strategy Group’s newly launched Washington D.C. showroom, the SSG
Solutions Center. Secure Strategy Group has been a consultant to Implant
Sciences since February 2009.

The SSG Solutions Center enables buyers, including government agencies,
prime contractors, and systems integrators, to “touch and feel” Implant’s
products. The SSG Solutions Center is located at the Center for
Innovative Technology (CIT), a world-class office complex located less
than five minutes from Dulles Airport, right in the heart of Washington,
D.C.’s technology corridor.

Scott Greiper, founder and President of SSG, stated, “We’ve selected
Implant Sciences and its products for showcase because Implant’s
portable, highly effective and cost-efficient QS-H150 directly addresses
one of the fastest growing sectors in homeland security.”

Robert Liscouski, Implant Sciences board member and SSG partner and Head
of Business Development and Strategy, added, “Being part of the permanent
display at the SSG Solutions Center will help Implant Sciences reach key
purchasers and opinion leaders in Washington. We hope this visibility
will lead to sales growth while decreasing associated operational
expenses for Implant.”

“We are pleased and honored to be selected by Secure Strategy Group as a
best of breed solutions provider. This is a very efficient way for our
products to gain further traction and continue to enhance our revenue
outlook,” stated Implant Sciences CEO, Glenn Bolduc.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors
and systems for Security, Safety, and Defense (SS&D) markets. The Company
has developed proprietary technologies used in its commercial explosive
trace detection systems which ship to a growing number of locations
domestically and internationally. For further details on the Company and
its products, please visit the Company’s website at
www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements,” as
that term is defined in the Private Securities Litigation Reform Act of
1995. Such statements are based on management’s current expectations and
are subject to risks and uncertainties that could cause the Company’s
actual results to differ materially from the forward-looking statements.
Such risks and uncertainties include, but are not limited to, the risks
that our explosives detection products and technologies (including any
new products we may develop) may not be accepted by the U.S. government
or by other law enforcement agencies or commercial consumers of security
products; our business is subject to intense competition and rapid
technological change; and other risks and uncertainties described in our
filings with the Securities and Exchange Commission, including its most
recent Forms 10-K, 10-Q and 8-K. Such statements are based on
management’s current expectations and assumptions which could differ
materially from the forward-looking statements.

Contact:

Implant Sciences Corporation
Company Contact:
Glenn Bolduc, CEO
978-752-1700
gbolduc@implantsciences.com
or

Investor Contact:
Laurel Moody
646-810-0608
lmoody@corporateprofile.com

Copyright 2010, Market Wire, All rights reserved.